Pills masthead

Senior Management

Timothy C. Crew

Chief Executive Officer

Timothy C. Crew was appointed as the Company’s Chief Executive Officer and a Director of the Company in January 2018.  Mr. Crew has more than 30 years of experience in the generic and branded pharmaceutical industries.  Previously, he served as Chief Executive Officer of Cipla North America, a global pharmaceutical company based in Mumbai, India.  Before Cipla, he worked for eight years at Teva Pharmaceuticals Industries Ltd. (“Teva”), where he ultimately served as Senior Vice President and Commercial Operating Officer of the North American Generics division, the world’s largest generic operation with multibillion dollars of annual sales.  Before that, he was Teva’s Vice President, Alliances and Business Development.  Mr. Crew was also an Executive Vice President, North America, for Dr. Reddy’s Laboratories Ltd.  Mr. Crew began his pharmaceutical career at Bristol-Myers Squibb, where he held a number of senior management positions in global marketing, managed healthcare, marketing, business development and strategic planning.  Prior to his pharmaceutical roles, Mr. Crew served in the United States Army, where he rose to the rank of Captain. Mr. Crew earned a Bachelor of Arts degree in economics from Pomona College and a Masters of Business Administration degree from Columbia Business School.

John Kozlowski

Vice President of Finance & Chief Financial Officer

John Kozlowski joined Lannett Company in 2009. During his tenure at the company, John has held a number of senior level finance positions, including corporate controller and vice president financial operations. In 2017, John was promoted to chief operating officer. In this role, he was responsible for strategic planning and primary business operations, including production, R&D, business development, marketing, supply chain, regulatory, and quality. In 2019, John was promoted to Vice President of Finance and Chief Financial Officer.

Prior to joining the company, John served in senior finance and accounting roles for Optium Corporation and Finisar Australia. He earned his Bachelor of Arts degree in finance from James Madison University and a Master of Business Administration degree from Rider University.

Samuel H. Israel

Chief Legal Officer and General Counsel

Samuel H. Israel was appointed vice president, chief legal officer and general counsel in July 2017.  Prior to joining Lannett, Mr. Israel was a partner with Fox Rothschild, a national, full-service law firm, with 22 offices that provide services in more than 60 practice areas.  He served as chair of the firm’s Pharmaceutical and Biotechnology Practice and handled a variety of commercial litigation matters.  Mr. Israel earned a Bachelor of Science degree in chemical engineering from the University of Pennsylvania and a Juris Doctor degree with honors from Rutgers University School of Law.

Maureen Cavanaugh

Senior VP & Chief Commercial Operations Officer

Maureen Cavanaugh joined Lannett as Senior Vice president and Chief Commercial Operations officer in 2018. Maureen is responsible for overseeing operations including sales and marketing, research and development (R&D) and regulatory affairs. With nearly 30 years of pharmaceutical industry experience, Maureen’s expertise includes new product launch planning and execution, strategic product management, identifying portfolio opportunities, and other critical operational functions.

Prior to joining Lannett, Maureen was the senior vice president, chief commercial officer, North America Generics, at Teva Pharmaceuticals USA. Prior to that, Maureen held a variety of senior positions in other leading companies in the pharmaceutical industry, including PAR, Sandoz, and Bristol Myers-Squibb. Maureen earned her Bachelor of Science degree in Business Administration at LaSalle University and her Master of Business Administration degree from Rider University.

John M. Abt

VP & Chief Quality Operations Officer

John M. Abt joined Lannett Company as vice president of quality in 2015. Prior to joining Lannett, John served as vice president of global quality strategy at Teva Pharmaceuticals, where he oversaw the development and implementation of global quality operating plans, standardization and efficiency programs, and offshoring efforts, after taking on a number of quality and operations positions of increasing responsibility in the company.

John earned a Doctorate of Business Administration from Temple University, a Master of Administrative Sciences degree in management from Johns Hopkins University, and a Bachelor of Science degree in biochemistry from Niagara University.

Robert Ehlinger

Vice President and Chief Information Officer

Robert Ehlinger joined the company in July 2006 as chief information officer. In June 2011, he was promoted to vice president of logistics and chief information officer. Over his tenure, Bob has played a central role in leveraging technology to drive improvements throughout the organization. Following a major acquisition in 2015, he oversaw a two-year project to integrate and harmonize business processes for a consistent, streamlined platform across all plants. Under his leadership in IT, Lannett received a CIO 100 award in 2017 for distinguished work on automated testing tools and solutions.

Prior to joining Lannett, Bob was the vice president of information technology at MedQuist, Inc., a healthcare services provider.  Over his 10-year career at MedQuist, he held a number of operational and technology positions of increasing responsibility. Prior to MedQuist, he was the corporate director of information technology supporting acute care and ambulatory care health information systems and biomedical support services at Kennedy Health Systems (now Jefferson Health). Bob earned a Bachelor of Arts degree in physics from Gettysburg College in Gettysburg, PA.

Price Data